CO-INFXN (Anaplasma Phagocytophilum, Babesia Microti, Bartonella Henselae, Borrelia Burgdorferi Nosode, Ehrlichia Nosode (Canine), Encephalitis Nosode, Mycoplasma Pneumoniae, Meningococcus Nosode, Hepatitis B Nosode) Liquid Deseret Biologicals, Inc.
Updated Date: May 20, 2019 EST
In this study, the potential of bardoxolone methyl (BARD), an Nrf2 activator, was examined in cell culture systems against HBV and HCV. We investigated that BARD had a suppressive effect on the production of extracellular HBV DNA in several HBV culture systems. In addition, BARD treatment reduced the levels of intracellular HBV pregenome RNA (pgRNA), a transcript from the HBV genome and a template of HBV genome replication. HCV genome replication was also suppressed in HCV subgenomic replicon-bearing cells by BARD treatment. BARD might be a novel treatment for patients with HBV and HCV co-infection.
Authors: Kułak-Bejda A, Waszkiewicz N, Bejda G, Zalewska A, Maciejczyk M Abstract A growing interest in the usability of saliva has been observed recently. Using saliva as a diagnostic material is possible because it contains a varied range of composites, organic and inorganic like proteins, carbohydrates, and lipids, which are secreted into saliva. Moreover, this applies to drugs and their metabolites. Saliva collection is noninvasive, and self-collection is possible. There is a lack of risk of injuries related to injection with needle, and it is generally safe. Human saliva has been successfully used, for exampl...
In this study we investigated anti-melanoma and hepatoprotective activities of frankincense essential oil (FEO) in both in vitro and in vivo models. Pretreatment with FEO induce a significant (p
Conclusions: Our findings demonstrated that serum immunoglobulins were preferentially elevated in HBV-ACLF patients. IgG levels were positively correlated with IL-27 and may predict prognosis in HBV-ACLF patients. PMID: 31198792 [PubMed - in process]
Authors: Mei JS, Li Q, Liao XF, Sun GH, Ding X, Wang ZX, Ouyang YL, Jiang T, Li CB PMID: 31190511 [PubMed - in process]
It got its start in developing a urine test for human growth hormones. But it hopes to go well beyond that now.
Updated Date: Mar 29, 2019 EST
Updated Date: Feb 28, 2018 EST
Updated Date: Sep 8, 2017 EST
Updated Date: Apr 15, 2015 EST